# XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)

Study · id `cardio:ct-nct05881278` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05881278](<https://clinicaltrials.gov/study/NCT05881278>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05881278

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 141 participants.

## Technical summary

Registry record NCT05881278. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-10 (actual); primary completion 2025-11-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 141 participants (planned count; ClinicalTrials.gov record NCT05881278, source copy `cardio:ctgov-nct05881278-2026-08-17`, retrieved 2026-10-26)
- Started: 2023-10-10 (actual) (ClinicalTrials.gov record NCT05881278, source copy `cardio:ctgov-nct05881278-2026-08-17`, retrieved 2026-10-26)
- Primary completion: 2025-11-22 (actual) (ClinicalTrials.gov record NCT05881278, source copy `cardio:ctgov-nct05881278-2026-08-17`, retrieved 2026-10-26)
- Completion: 2029-11 (anticipated) (ClinicalTrials.gov record NCT05881278, source copy `cardio:ctgov-nct05881278-2026-08-17`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05881278, source copy `cardio:ctgov-nct05881278-2026-08-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05881278-2026-08-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
- Condition: Heart Failure
- Condition: Transplant; Failure, Heart
- Intervention (Device): Non-Ischemic Heart Preservation (NIHP) using the XVIVO Heart Preservation System (XHPS)
- Lead sponsor: XVIVO Perfusion
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: d02b83e872ab3c3259c400d340e53938bdba67843b5cc0ae71c3d67934dca689
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
